language-icon Old Web
English
Sign In
Acemap > Paper > 新規透析導入後rHuEPO製剤未投与の血液透析患者を対象とした貧血改善用量検討試験-KRN321 (Darbepoetin alfa) 第III相臨床試験-

新規透析導入後rHuEPO製剤未投与の血液透析患者を対象とした貧血改善用量検討試験-KRN321 (Darbepoetin alfa) 第III相臨床試験-

2007 
Keywords:
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    0
    Citations
    NaN
    KQI
    []
    logo
    • CCF Conference Analysis
    • Map Galaxy
    • What's New
    © Copyright 2015-2020 Acemap, Inc. Shanghai Jiao Tong University.